Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
User feedback can provide valuable insights into no fee travel points cards. Discover what real users are saying to make an informed choice.
16,741 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Pony AI reports unit-level profitability in Guangzhou but faces a long road to company-wide profits as it scales flee...
Lawmakers remain at an impasse on reforms as Social Security heads toward solvency risk in roughly six years. The inv...
Cardano’s ADA traded near the 26-cent mark as regulators named ADA a digital commodity, boosting optimism while price...
NVIDIA stock is under pressure as a wave of AI infrastructure spending by the Magnificent Seven tests profits versus ...
If you’re worried about stock market volatility, defensive dividend stocks can help. This guide covers smart picks, s...
A 2025 performance-year pay surge pushed the average wall street bonus to around $210,000, about three times the typi...
Cybersecurity stocks tumbled as Anthropic rolled out a new AI model, sending Palo Alto Networks and other peers lower...
Newmont Mining stock rebounded on Friday as gold prices rallied and investors rotated into safe-haven assets. This gu...
If you’re playing the long game, XRP could ride a growing payments ecosystem, regulatory clarity, and broader crypto ...
Hyperscale AI demand is tightening packaging capacity. Intel's EMIB-T presents a potential workaround as chip packagi...
Bitcoin trades near $81,000 as a decisive 72-hour window begins for the crypto market. Traders weigh ETF inflows, liq...